We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$38.4B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
-2.96%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$21.8B
AUM Growth
-$767M
(-3.4%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
1,924
New
62
Increased
766
Reduced
660
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Watsco Inc
WSO
|
+$31.3M |
| 2 |
Tyler Technologies
TYL
|
+$24.6M |
| 3 |
Danaher
DHR
|
+$22.7M |
| 4 |
iRhythm Holdings
IRTC
|
+$20.9M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$20.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$77.8M |
| 2 |
Trex
TREX
|
+$39.7M |
| 3 |
DOCU
DocuSign
DOCU
|
+$17.2M |
| 4 |
Akamai
AKAM
|
+$16.6M |
| 5 |
SPDR Gold Trust
GLD
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.15% |
| 2 | Healthcare | 19.33% |
| 3 | Financials | 11.9% |
| 4 | Industrials | 11.25% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Ionis Pharmaceuticals
IONS
$9.28B
| $657K | ﹤0.01% |
14,844
+237
| +2% | +$9.99K |
|
952
Vita Coco
COCO
$3.77B
| $655K | ﹤0.01% |
57,500
| – | – |
|
953
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.5B
| $652K | ﹤0.01% |
11,181
+3,187
| +40% | +$193K |
|
|
LTCH
954
DELISTED
Latch, Inc. Common Stock
LTCH
| $652K | ﹤0.01% |
684,092
+347,287
| +103% | +$398K |
|
955
National Grid
NGG
$81.6B
| $650K | ﹤0.01% |
13,619
+191
| +1% | +$11.5K |
|
956
NiSource
NI
$20.2B
| $650K | ﹤0.01% |
25,797
+565
| +2% | +$16.6K |
|
957
Sony
SONY
$138B
| $650K | ﹤0.01% |
50,770
-6,060
| -11% | -$97.1K |
|
958
Golub Capital BDC
GBDC
$3.48B
| $649K | ﹤0.01% |
52,376
+1,000
| +2% | +$13.6K |
|
959
Bright Horizons
BFAM
$3.85B
| $647K | ﹤0.01% |
11,227
-3,531
| -24% | -$269K |
|
960
JPMorgan BetaBuilders Europe ETF
BBEU
$9.53B
| $645K | ﹤0.01% |
16,002
-505
| -3% | -$23K |
|
961
Advanced Drainage Systems
WMS
$11.3B
| $645K | ﹤0.01% |
5,184
+1,727
| +50% | +$215K |
|
962
Braze
BRZE
$3.36B
| $644K | ﹤0.01% |
+18,479
| New | +$780K |
|
963
Organon & Co
OGN
$3.6B
| $642K | ﹤0.01% |
27,432
+719
| +3% | +$21.7K |
|
964
Sanofi
SNY
$105B
| $630K | ﹤0.01% |
16,578
+7,486
| +82% | +$334K |
|
965
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.92B
| $628K | ﹤0.01% |
5,986
| – | – |
|
966
Genpact
G
$5.78B
| $626K | ﹤0.01% |
14,301
-4,781
| -25% | -$220K |
|
967
HUB Group
HUBG
$2.55B
| $625K | ﹤0.01% |
18,110
| – | – |
|
968
iShares US Healthcare ETF
IYH
$3.77B
| $617K | ﹤0.01% |
12,195
+895
| +8% | +$48.3K |
|
969
STAG Industrial
STAG
$7.12B
| $614K | ﹤0.01% |
21,589
+13,000
| +151% | +$410K |
|
970
Vodafone
VOD
$37.5B
| $612K | ﹤0.01% |
54,010
-11,961
| -18% | -$167K |
|
971
US Global Jets ETF
JETS
$832M
| $610K | ﹤0.01% |
40,649
-4,945
| -11% | -$86K |
|
972
Ross Stores
ROST
$78.6B
| $609K | ﹤0.01% |
7,230
-298
| -4% | -$25.3K |
|
973
TaskUs
TASK
$667M
| $608K | ﹤0.01% |
+37,755
| New | +$666K |
|
974
Brown-Forman Class B
BF.B
$12.9B
| $606K | ﹤0.01% |
9,109
-2,421
| -21% | -$176K |
|
975
Viper Energy
VNOM
$14.8B
| $596K | ﹤0.01% |
20,800
| – | – |
|
Similar funds
HF
William Blair & Company's Q3 2022 Portfolio in Review
As of Q3 2022, William Blair & Company held 1,924 positions worth $21.8B, down 3.4% from $22.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
William Blair & Company's Q3 2022 filing shows 62 new, 766 increased, 660 reduced and 101 closed positions. Its largest new stake was GSK: 37,792 shares worth $1.11M. The largest sale was Atlassian, an estimated $77.8M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- William Blair & Company's largest Q3 2022 buy was GSK: 37,792 shares worth $1.11M.
- William Blair & Company added most to Watsco Inc in Q3 2022, an estimated $31.3M increase.
- William Blair & Company's biggest Q3 2022 reduction was Trex, cutting an estimated $39.7M.
- William Blair & Company fully exited Atlassian in Q3 2022, selling an estimated $77.8M.
- William Blair & Company's ten largest holdings make up 23% of its $21.8B portfolio in Q3 2022.
- William Blair & Company opened 62 new positions and closed 101 in Q3 2022.
- William Blair & Company's portfolio value fell 3.4% quarter-over-quarter to $21.8B.
Based on William Blair & Company's 13F filing for Q3 2022, filed 9 Nov 2022.